Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: A novel in vitro tumor model

Cancer Chemotherapy and Pharmacology

Volumn 52, Issue 4, 2003, Pages 263-269

  Walter Yohrling, Jennifer ^a,b   Pratt, Bruce M ^a   Ledbetter, Steve ^a   Teicher, Beverly A ^a  

^a GENZYME CORPORATION   (United States)

^b CENTOCOR INC   (United States)

Author keywords

Angiogenesis; In vitro model; Inhibitors; Invasion; Tumor stroma

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; ANGIOGENESIS INHIBITOR; COLLAGEN; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; PACLITAXEL;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL INTERACTION; CELL INVASION; CELL SUSPENSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYME CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; STROMA; THREE DIMENSIONAL IMAGING; TUMOR CELL; TUMOR GROWTH;

ADULT; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; METALLOPROTEASES; NEOPLASM INVASIVENESS; NEOPLASMS; PACLITAXEL; PROTEASE INHIBITORS; PYRROLES; STROMAL CELLS;

EID: 0141745162     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0664-2     Document Type: Article

References (33)

1. Adams EF, Newton CJ, Braunsberg H, Shaikh N, Ghilchik M, James VH (1988) Effects of human breast fibroblasts on growth and 17 beta-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res Treat 11:165
2. Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC, Chung LW (1990) Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A 87:75
3. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389
4. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103
5. Ehrlich HP, Rajaratnam JB (1990) Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell 22:407
6. Elenbaas B, Weinberg RA (2001) Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264:169
7. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Liu Donaher J, Popescu NC, Hahn WC, Weinberg RA (2001) Human breast cancer cell generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15:50
8. Gold LI (1999) The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncol 10:303
9. Hansen-Smith F, Egginton S, Zhou AL, Hudlicka O (2001) Growth of arterioles precedes that of capillaries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 62:1
10. Hirschi KK, Rohovsky SA, D'Amore PA (1998) PDGF, TGF-B and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805
11. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D'Amore PA (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:298
12. Janvier R, Sourla A, Koutsilieris M, Doillon CJ (1997) Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system. Anticancer Res 17:1551
13. Jones R, Jacobson M, Steudel W (1999) Alpha-smooth-muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension. Am J Resp Cell Mol Biol 20:582
14. Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong AT, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington JM (2000) SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res 60:4152
15. Lau DH, Xue L, Young LJ, Burge PA, Cheung AT (1999) Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. Cancer Biother Radiopharm 14:31
16. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE (1993) Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A 90:999
17. Mitchell J, Wookcock-Mitchell J, Reynolds S, Low R, Leslie K, Adler K, Gabbiani G, Skalli O (1989) Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab Invest 60:643
18. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi Y, Inoue S, Takahashi M, Hata T, Muramatsu M (2001) Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 7:3097
19. Park CC, Bissell MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6:324
20. Parrott JA, Nilsson E, Mosher R, Magrane G, Albertson D, Pinkel D, Gray JW, Skinner MK (2001) Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol Cell Endocrinol 175:29
21. Ronnov-Jessen L, Van Deurs B, Nielsen M, Petersen OW (1992) Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol 28A:273
22. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ (1995) The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95:859
23. Rowinsky EK, Donehower RC (1991) The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther 52:35
24. Sappino AP, Skalli O, Jackson B, Schurch W, Gabiani G (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41:707
25. Sato N, Sawasaki Y, Senoo A, Fuse Y, Hirano Y, Goto T (1987) Development of capillary networks from rat microvascular fragments in vitro: the role of myofibroblastic cells. Microvasc Res 33:194
26. Schurch W, Seemayer TA, Lagace R (1981) Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light, and electron microscopic study. Virchows Arch A 391:125
27. Schurch W, Seemayer TA, Gabbiani G (1998) The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 22:141
28. Shekhar MPV, Werdell J, Santner SJ, Pauley RJ, Tait L (2001) Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61:1320
29. Teicher BA (2001) Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 20:133
30. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62:3298
31. Vaughan MB, Howard EW, Tomasek JJ (2000) Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblasts. Exp Cell Res 257:180
32. Villaschi S, Nicosia RF (1994) Paracrine interaction between fibroblasts and endothelial cells in a serum-free coculture model. Modulation of angiogenesis and collagen gel contraction. Lab Invest 71:291
33. Walter JJ, Sane DC (2002) The role of smooth muscle cells and pericytes in angiogenesis. In: S. Mousa (ed) Angiogenesis inhibitors and stimulators: potential therapeutic implications. Landes and Springer, Georgetown, TX, p 25